TVTX logo

Travere Therapeutics (TVTX) Long Term Debt

Annual Long Term Debt

$327.50 M
-$72.37 M-18.10%

December 31, 2024


Summary


Performance

TVTX Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXbalance sheetmetrics:

Quarterly Long Term Debt

$327.50 M
-$1.04 M-0.32%

December 1, 2024


Summary


Performance

TVTX Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

TVTX Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-18.1%-18.1%
3 y3 years+26.9%-18.1%
5 y5 years+59.9%-18.1%

TVTX Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.8%+26.9%-19.1%+26.9%
5 y5-year-18.8%+59.9%-19.1%+59.9%
alltimeall time-18.8%+656.6%-19.1%+656.6%

Travere Therapeutics Long Term Debt History

DateAnnualQuarterly
Dec 2024
$327.50 M(-18.1%)
-
Dec 2024
-
$327.50 M(-0.3%)
Sep 2024
-
$328.54 M(-17.5%)
Jun 2024
-
$398.06 M(-0.2%)
Mar 2024
-
$398.98 M(-0.2%)
Dec 2023
$399.88 M(-0.8%)
$399.88 M(-0.2%)
Sep 2023
-
$400.70 M(-0.2%)
Jun 2023
-
$401.51 M(-0.2%)
Mar 2023
-
$402.30 M(-0.2%)
Dec 2022
$403.06 M(+56.2%)
$403.06 M(-0.1%)
Sep 2022
-
$403.38 M(-0.2%)
Jun 2022
-
$404.05 M(-0.2%)
Mar 2022
-
$404.77 M(+56.8%)
Dec 2021
$258.08 M(+5.9%)
$258.08 M(+15.4%)
Sep 2021
-
$223.70 M(+1.3%)
Jun 2021
-
$220.86 M(+1.3%)
Mar 2021
-
$218.08 M(-10.5%)
Dec 2020
$243.68 M(+18.9%)
$243.68 M(+14.6%)
Sep 2020
-
$212.65 M(+1.3%)
Jun 2020
-
$210.01 M(+1.3%)
Mar 2020
-
$207.41 M(+1.2%)
DateAnnualQuarterly
Dec 2019
$204.86 M(+5.0%)
$204.86 M(+1.2%)
Sep 2019
-
$202.35 M(+1.2%)
Jun 2019
-
$199.89 M(+1.2%)
Mar 2019
-
$197.47 M(+1.2%)
Dec 2018
$195.09 M(+332.8%)
$195.09 M(+1.2%)
Sep 2018
-
$192.75 M(+326.1%)
Mar 2018
-
$45.24 M(+0.4%)
Dec 2017
$45.08 M(+1.5%)
$45.08 M(+0.4%)
Sep 2017
-
$44.91 M(+0.4%)
Jun 2017
-
$44.75 M(+0.4%)
Mar 2017
-
$44.58 M(+0.4%)
Dec 2016
$44.42 M(+1.5%)
$44.42 M(+0.4%)
Sep 2016
-
$44.26 M(+0.4%)
Jun 2016
-
$44.09 M(+0.4%)
Mar 2016
-
$43.93 M(+0.4%)
Dec 2015
$43.77 M(+1.1%)
$43.77 M(+0.0%)
Sep 2015
-
$43.75 M(+0.4%)
Jun 2015
-
$43.59 M(-48.3%)
Mar 2015
-
$84.24 M(+94.6%)
Dec 2014
$43.29 M
$43.29 M(-48.0%)
Sep 2014
-
$83.29 M(+0.6%)
Jun 2014
-
$82.81 M

FAQ

  • What is Travere Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Travere Therapeutics?
  • What is Travere Therapeutics annual long term debt year-on-year change?
  • What is Travere Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Travere Therapeutics?
  • What is Travere Therapeutics quarterly long term debt year-on-year change?

What is Travere Therapeutics annual long term debt?

The current annual long term debt of TVTX is $327.50 M

What is the all time high annual long term debt for Travere Therapeutics?

Travere Therapeutics all-time high annual long term debt is $403.06 M

What is Travere Therapeutics annual long term debt year-on-year change?

Over the past year, TVTX annual long term debt has changed by -$72.37 M (-18.10%)

What is Travere Therapeutics quarterly long term debt?

The current quarterly long term debt of TVTX is $327.50 M

What is the all time high quarterly long term debt for Travere Therapeutics?

Travere Therapeutics all-time high quarterly long term debt is $404.77 M

What is Travere Therapeutics quarterly long term debt year-on-year change?

Over the past year, TVTX quarterly long term debt has changed by -$72.37 M (-18.10%)